Načítá se...
P04.02 Adoptive transfer of lymphokine activated NK cells in combination with anti-PD-1 immune checkpoint inhibitor in therapy of glioblastoma
BACKGROUND: Adoptive immunotherapy based on transfusions of ex vivo activated natural killer (NK) cells could increase the survival of neuro-oncological patients. 14-mer peptide TKDNNLLGRFELSG (TKD) residing in the amino acid sequence of aa(450-463) of the C-terminal domain of Hsp70 and low dose IL-...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144709/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.236 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|